• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】CI-949

【化学名称】5-Methoxy-3-(1-methylethoxy)-1-phenyl-N-(1H-tetrazol-5-yl)-1H-indole-2-carboxamide L-arginine salt
      3-Isopropoxy-5-methoxy-1-phenyl-N-(1H-tetrazol-5-yl)-1H-indole-2-carboxamide L-arginine salt

【CA登记号】104961-35-5

【 分 子 式 】C26H34N10O5

【 分 子 量 】566.62488

【开发单位】Pfizer (Originator)

【药理作用】Antiallergy/Antiasthmatic Drugs, Asthma Therapy, RESPIRATORY DRUGS, Mediator Release Inhibitors

合成路线1

The alkylation of 3-hydroxy-5-methoxy-1-phenylindole-2-carboxylic acid methyl ester (I) with isopropyl bromide (II) and KOH gives the corresponding 2-isopropoxy compound (III), which is hydrolyzed with KOH and HOAc, yielding the carboxylic acid (IV). The condensation of (IV) with 1H-tetrazol-5-amine (V) by means of CDI affords the expected amide (VI), which is finally treated with L-arginine to furnish the target arginine salt.

1 Unangst, P.C.; Carethers, M.E.; Indole esters as heterocyclic synthons. III. Preparation and reactions of furo[3,2-b]indoles. J Heterocycl Chem 1984, 21, 709-714.
2 Kunz, K.; Friendlander, P.; Concerning N,N'-diphenyl-indigo. Chem Ber 1922, 55, 1597-1607.
3 Unangst, P.C.; Conroy, M.C.; CI-949 AND RELATED INDOLECARBOXAMIDOTETRAZOLES: A NEW CLASS OF POTENTIAL ANTIALLERGY AGENTS. Drugs Fut 1990, 15, 10, 1005.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 42913 methyl 3-hydroxy-5-methoxy-1-phenyl-1H-indole-2-carboxylate C17H15NO4 详情 详情
(II) 32658 2-bromopropane 75-26-3 C3H7Br 详情 详情
(III) 42914 methyl 3-isopropoxy-5-methoxy-1-phenyl-1H-indole-2-carboxylate C20H21NO4 详情 详情
(IV) 42915 3-isopropoxy-5-methoxy-1-phenyl-1H-indole-2-carboxylic acid C19H19NO4 详情 详情
(V) 14092 1H-1,2,3,4-Tetraazol-5-ylamine; 1H-Tetrazol-5-amine; 1H-1,2,3,4-Tetraazol-5-amine; 5-Amino-1H-1,2,3,4-tetrazole 4418-61-5 CH3N5 详情 详情
(VI) 42916 3-isopropoxy-5-methoxy-1-phenyl-N-(1H-1,2,3,4-tetraazol-5-yl)-1H-indole-2-carboxamide C20H20N6O3 详情 详情
(VII) 42917 L-2-Amino-5-guanidinopentanoic acid; (S)-(+)-Arginine; L-Arginine 74-79-3 C6H14N4O2 详情 详情
Extended Information